ATC code C09

ATC code C09 Agents acting on the renin–angiotensin system is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3] Subgroup C09 is part of the anatomical group C Cardiovascular system.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC09.^[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

C09A ACE inhibitors, plain

C09AA ACE inhibitors, plain

C09AA01 Captopril

C09AA02 Enalapril

C09AA03 Lisinopril

C09AA04 Perindopril

C09AA05 Ramipril

C09AA06 Quinapril

C09AA07 Benazepril

C09AA08 Cilazapril

C09AA09 Fosinopril

C09AA10 Trandolapril

C09AA11 Spirapril

C09AA12 Delapril

C09AA13 Moexipril

C09AA14 Temocapril

C09AA15 Zofenopril

C09AA16 Imidapril

C09B ACE inhibitors, combinations

C09BA ACE inhibitors and diuretics

C09BA01 Captopril and diuretics

C09BA02 Enalapril and diuretics

C09BA03 Lisinopril and diuretics

C09BA04 Perindopril and diuretics

C09BA05 Ramipril and diuretics

C09BA06 Quinapril and diuretics

C09BA07 Benazepril and diuretics

C09BA08 Cilazapril and diuretics

C09BA09 Fosinopril and diuretics

C09BA12 Delapril and diuretics

C09BA13 Moexipril and diuretics

C09BA15 Zofenopril and diuretics

C09BB ACE inhibitors and calcium channel blockers

C09BB02 Enalapril and lercanidipine

C09BB03 Lisinopril and amlodipine

C09BB04 Perindopril and amlodipine

C09BB05 Ramipril and felodipine

C09BB06 Enalapril and nitrendipine

C09BB07 Ramipril and amlodipine

C09BB10 Trandolapril and verapamil

C09BB12 Delapril and manidipine

C09BB13 Benazepril and amlodipine

C09BX ACE inhibitors, other combinations

C09BX01 Perindopril, amlodipine and indapamide

C09BX02 Perindopril and bisoprolol

C09BX03 Ramipril, amlodipine and hydrochlorothiazide

C09BX04 Perindopril, bisoprolol and amlodipine

C09BX05 Ramipril and bisoprolol

C09BX06 Perindopril, bisoprolol, amlodipine and indapamide

C09BX07 Zofenopril and nebivolol

QC09BX90 Benazepril and pimobendan

C09C Angiotensin II receptor blockers (ARBs), plain

C09CA Angiotensin II receptor blockers (ARBs), plain

C09CA01 Losartan

C09CA02 Eprosartan

C09CA03 Valsartan

C09CA04 Irbesartan

C09CA05 Tasosartan

C09CA06 Candesartan

C09CA07 Telmisartan

C09CA08 Olmesartan medoxomil

C09CA09 Azilsartan medoxomil

C09CA10 Fimasartan

C09D Angiotensin II receptor blockers (ARBs), combinations

C09DA Angiotensin II receptor blockers (ARBs) and diuretics

C09DA01 Losartan and diuretics

C09DA02 Eprosartan and diuretics

C09DA03 Valsartan and diuretics

C09DA04 Irbesartan and diuretics

C09DA06 Candesartan and diuretics

C09DA07 Telmisartan and diuretics

C09DA08 Olmesartan medoxomil and diuretics

C09DA09 Azilsartan medoxomil and diuretics

C09DA10 Fimasartan and diuretics

C09DB Angiotensin II receptor blockers (ARBs) and calcium channel blockers

C09DB01 Valsartan and amlodipine

C09DB02 Olmesartan medoxomil and amlodipine

C09DB04 Telmisartan and amlodipine

C09DB05 Irbesartan and amlodipine

C09DB06 Losartan and amlodipine

C09DB07 Candesartan and amlodipine

C09DB08 Valsartan and lercanidipine

C09DB09 Fimasartan and amlodipine

C09DX Angiotensin II receptor blockers (ARBs), other combinations

C09DX01 Valsartan, amlodipine and hydrochlorothiazide

C09DX02 Valsartan and aliskiren

C09DX03 Olmesartan medoxomil, amlodipine and hydrochlorothiazide

C09DX04 Valsartan and sacubitril

C09DX05 Valsartan and nebivolol

C09DX06 Candesartan, amlodipine and hydrochlorothiazide

C09DX07 Irbesartan, amlodipine and hydrochlorothiazide

C09DX08 Telmisartan, amlodipine and hydrochlorothiazide

C09X Other agents acting on the renin–angiotensin system

C09XA Renin-inhibitors

C09XA01 Remikiren

C09XA02 Aliskiren

C09XA52 Aliskiren and hydrochlorothiazide

C09XA53 Aliskiren and amlodipine

C09XA54 Aliskiren, amlodipine and hydrochlorothiazide

References

^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^ "ATC/DDD Index 2022: code C09". WHO Collaborating Centre for Drug Statistics Methodology.
^ "ATCvet Index 2022: code QC09". WHO Collaborating Centre for Drug Statistics Methodology.

[1] "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.

[2] World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.

[3] "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.

[4] "ATC/DDD Index 2022: code C09". WHO Collaborating Centre for Drug Statistics Methodology.

[5] "ATCvet Index 2022: code QC09". WHO Collaborating Centre for Drug Statistics Methodology.

[1]

[2]

[3]

[4]

[5]

v t e Antihypertensive drugs acting on the renin–angiotensin system (C09)
ACE inhibitors ("-pril")	Sulfhydryl-containing: Captopril Rentiapril Zofenopril (+nebivolol) Dicarboxylate-containing: Enalapril^# (+lercanidipine, +nitrendipine) Benazepril (+amlodipine, +pimobendan) Cilazapril Delapril (+manidipine) Imidapril Lisinopril (+amlodipine, +HCT) Moexipril Perindopril (+amlodipine, +bisoprolol, +indapamide, +amlodipine and indapamide, +bisoprolol and amlodipine, +bisoprolol, amlodipine, and indapamide) Quinapril (+HCT) Ramipril (+amlodipine, +amlodipine and HCT, +bisoprolol, +felodipine) Spirapril Temocapril Trandolapril (+verapamil) Phosphonate-containing: Ceronapril Fosinopril (+HCT) Other/ungrouped: Alacepril
AIIRAs ("-sartan")	Azilsartan Candesartan (+amlodipine, +amlodipine and HCT) Eprosartan Fimasartan Irbesartan (+amlodipine, +amlodipine and HCT, +HCT) Losartan (+amlodipine, +HCT) Olmesartan (+amlodipine, +amlodipine and HCT, +HCT) Tasosartan^§ Telmisartan (+amlodipine, +amlodipine and HCT, +HCT) Valsartan (+aliskiren, +amlodipine, +amlodipine and HCT, +HCT, +lercanidipine, +nebivolol, +sacubitril)
Renin inhibitors ("-kiren")	Aliskiren (+amlodipine, +HCT, +amlodipine and HCT) Remikiren^§
Dual ACE/NEP inhibitors	Gemopatrilat Ilepatril Omapatrilat Sampatrilat
Neprilysin inhibitors	Sacubitril (+valsartan)
Other	Sparsentan
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

ATC code C: Cardiovascular system
C01 Cardiac therapy C02 Antihypertensives C03 Diuretics C04 Peripheral vasodilators C05 Vasoprotectives C07 Beta blocking agents C08 Calcium channel blockers C09 Agents acting on the renin–angiotensin system C10 Lipid modifying agents
Other ATC codes
A B C D G H QI J L M N P R S V